Djibril Wade

Djibril Wade

Doctor

Institut de Recherche en Santé, de Surveillance Epidémiologique et de Formations (IRESSEF), Senegal

Email: djibril.wade@iressef.org

 

 

 

 

VALIDATE Role:

Network Associate

 

Research Keywords: 

HIV, Ebola, TB, Malaria, clinical trials

 

Biography:

After his Masters in Animal Biology in 2009, Djibril Wade was trained on all aspects of the biological follow-up of HIV patients during the University course on Biological Retrovirology. In 2011, he was awarded a PhD Scholarship from DGD (Belgian Directorate General for Development Cooperation) to start a PhD sandwich between Dakar, Senegal (Laboratory of Bacteriology Virology at Le Dantec Hostpital) and Antwerp, Belgium (Institute of Tropical Medicine). He was registered at the Universtiy of Antwerp as a PhD student at the Department of Biomedical Sciences. During his PhD, he assisted the Senegalese National ART Program to implement the CD4 Quality Control Program and to decentralize CD4 monitoring. He obtained his PhD degree in Biomedical Sciences at the University of Antwerp (Belgium) in June 2015, under the supervision of Prof Dr Luc Kestens (Belgium) and Prof Dr Souleymane Mboup (Senegal). After that, he coordinated the Phase 2b Ebola vaccine trial in Dakar. As a scientist, Djibril Wade authored 3 peer-reviewed papers published in International Journals and co-authored 5 others. He has attended and presented his work at different scientific meetings.

 

Related Websites: 

LinkedIn

 

Key Publications:

Daneau G, Buyze J, Wade D, Diaw PA, Dieye TN, Thai S, Florence E, Lynen L, Kestens L. CD4 results with a bias larger than hundred cells per microliter can have a significant impact on the clinical decision during treatment initiation of HIV patients. Cytometry B Clin Cytom. 2016 Feb 25. doi: 10.1002/cyto.b.21366.  PMID: 26917223

Wade D, Diaw PA, Daneau G, Diallo AA, Mboup S, Dieye TN, Kestens L. Laboratory and field evaluation of the Partec CyFlow miniPOC for absolute and relative CD4 T-cell enumeration. PLoS One. 2015 Feb 17;10(2):e0116663. doi: 10.1371/journal.pone.0116663. eCollection 2015. PMID: 25688553

Wade D, Daneau G, Aboud S, Vercauteren GH, Urassa WS, Kestens L. WHO multicenter evaluation of FACSCount CD4 and Pima CD4 T-cell count systems: instrument performance and misclassification of HIV-infected patients. J Acquir Immune Defic Syndr. 2014 Aug 15;66(5):e98-107. doi: 10.1097/QAI.0000000000000214. PMID: 24853304

Wade D, Diaw PA, Daneau G, Camara M, Dieye TN, Mboup S, Kestens L. CD4 T-cell enumeration in a field setting: evaluation of CyFlow counter using the CD4 easy count kit-dry and Pima CD4 systems. PLoS One. 2013 Sep 16;8(9):e75484. doi: 10.1371/journal.pone.0075484. eCollection 2013. PMID: 24066184

Moustapha Mbow et al. HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subsets of regulatory T-cells in HIV-1 infection patients. African Journal of Laboratory Medicine, 2013; 2(1):8pp